Skip to content
Medical Health Aged Care

KFSHRC’s DCEO Highlights Medical Tourism Growth at Arab Health 2025

King Faisal Specialist Hospital & Research Centre 2 mins read

Advanced Tech and Global Collaborations Attract Patients from 17 Countries

KFSHRC’s DCEO Highlights Medical Tourism Growth at Arab Health 2025

RIYADH, Saudi Arabia, Jan. 28, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) Deputy Chief Executive Officer, Dr. Björn Zoëga, represented KFSHRC at the region’s premier healthcare event, Arab Health 2025, held recently in Dubai. Dr. Zoëga participated in a panel discussion titled “Investing in KSA’s Healthcare Future”.

The panel discussion emphasized KFSHRC’s critical contributions to advancing Saudi Arabia’s healthcare sector and its ambition to become a global healthcare hub. Dr. Zoëga highlighted how KFSHRC’s adoption of advanced technologies, including AI-powered diagnostics, robotic-assisted surgeries, and telemedicine services, supports the Kingdom’s Health Sector Transformation Program. These innovations enhance the quality and accessibility of care, attracting 46,476 new patients in 2024, including a 47.39% increase in medical tourism cases with patients from 17 countries, reinforcing Saudi Arabia’s position as a global healthcare hub.

Dr. Zoëga underscored KFSHRC’s global collaborations, which have facilitated knowledge exchange and introduced best practices into Saudi Arabia’s healthcare ecosystem.

King Faisal Specialist Hospital and Research Centre is a 2443-bed tertiary/quaternary care hospital with facilities in Riyadh, Jeddah, and Madinah in the Kingdom of Saudi Arabia. It has over 17,000 employees from over 63 nationalities. KFSHRC specialises in inpatient and outpatient medical care, with excellent centers in Oncology, Organ Transplantation, Cardiovascular Diseases, Neurosciences, and Genetic Diseases. It is recognised and ranked globally as one of the top hospitals, as on Newsweek’s and Brand Finance's World's Best Hospitals—Top 250 lists. KFSHRC’s International Services adhere to the highest global standards, reflected in the performance of 5K+ bone marrow and 4K+ solid organ transplants, 3K+ robotic-assisted procedures, 2K+ submitted cardiovascular inpatients annually, and much more. For more information, please visit www.kfshrc.edu.sa or contact our media team at [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fae16a0e-e0ee-4bb1-ada3-a21fc59da98d


Primary Logo

More from this category

  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:
  • Medical Health Aged Care, Science
  • 17/12/2025
  • 07:56
Australian and New Zealand Journal of Public Health

Summer Mozzie Warning – Ross River Virus risk linked to warmer temperatures

17 December 2025 - Australians are being urged to prevent mosquito bites this summer, after research mapping studies from across the country found that warmer temperatures heighten the risk of Ross River Virus outbreaks, especially inriverland and coastal regions. The scoping review, led by the University of Adelaide, and published today in the Australian and New Zealand Journal of Public Health, also uncovered a knowledge gap when it comes to understanding the impact of temperature on Ross River Virus notifications within inland Australia. Ross River Virus is a common mosquito-borne diseases in Australia, with around 3,000 cases reported annually. It…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 17/12/2025
  • 06:00
Leukaemia Foundation

Leukaemia Foundation welcomes South Australian Government commitment to establish dedicated CAR T therapy service

The Leukaemia Foundation has welcomed the announcement by theMalinauskas Labor Government that South Australia is establishing a dedicated CAR T-cell therapy service as a line of treatment for people living with blood cancer – marking a major advancement in cancer care in the State. The new service, expected to commence by mid-2026, will significantly improve access to this highly specialised, life-saving treatment and reduce the need for South Australians to travel interstate for care. Leukaemia Foundation Chief Executive Officer Chris Tanti said the announcement represented a huge win for blood cancer patients and their families. “This is a landmark step…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.